The number of shares that changed hands amount to 8% of the company’s outstanding equity.
Shares changed hands at an average price of ₹624 per share, taking the total transaction value to ₹793 crore.
Buyers and sellers in the transaction remains undisclosed so far.
CNBC-TV18 had reported on Tuesday that the deal is likely to take place in the block deal window. The indicative floor price was supposed to be ₹630 – ₹631 per share, amounting to a 3% discount to Tuesday’s closing price.
At the end of the June quarter, promoters of Thyrocare had a 61% stake in the company, based on the shareholding pattern updated by the company on the BSE.
Among the public shareholders, Mutual Funds had a 19.86% stake in the company, including Nippon India MF (5.99%), ICICI Prudential MF (5.57%), HSBC MF (3.84%), and Aditya Birla Sun Life AMC (3.15%).
Foreign portfolio investors had a 5.5% stake in the company at the end of June.
Close to 70,000 small retail shareholders, or those with authorized share capital of up to ₹2 lakh, had a 8.57% stake in the company as on June 30.
Thyrocare had issued a bonus in November last year, where shareholders had received two free shares for every one share they owned as on the record date (2:1). The company has also regularly paid dividends to its shareholders.
Shares of Thyrocare ended 4.5% higher on Tuseday at ₹649.45. The stock has risen 27% over the last one month, taking its year-to-date advance to 45.5%.
